Menu
A screenshot of a section of Johnson & Johnson's updated Pharmaceutical Manufacturer Configuration document.
Johnson & Johnson recently updated its Pharmaceutical Manufacturer Configuration, which details how industry vendor Beacon Channel Management must process MFP rebates in 2026.

J&J Unveils ‘Interim’ MFP Plan Amid 340B Rebate Pilot’s Pause

Shannon Young, Associate Editor/Senior Writer 340B Report Views
A major drugmaker selected to take part in the Health Resources and Services Administration’s (HRSA) 340B rebate model recently announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Sagebrush Sues Amgen for Allegedly Ending Access to 340B Discounts

House Lawmakers Note Concerns with HRSA Rebate Pilot in Health Spending Package Documents

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live